Immunocastration offers a welfare-friendly alternative to surgical castration in pigs, preventing boar taint while avoiding the pain and stress of surgical procedures.
Immunocastration represents one of the most well-developed examples of a welfare-friendly technological alternative to a routine painful farm practice. Surgical castration of piglets, even in the first week of life, causes acute pain - piglets vocalise and show pain behaviour during and after the procedure, and tissue healing involves a period of ongoing discomfort. While pain relief is increasingly used in some countries, the majority of European surgical castrations occur without anaesthesia or analgesia. Immunocastration avoids all surgical pain and the associated stress, while achieving the production objective of preventing boar taint. The welfare case is clear and the technology is well-established. The barriers to adoption are market-side: some consumers object to the use of vaccines in food production (despite immunocastration having no food safety implications, as the vaccine is cleared before slaughter), and some retailers have been reluctant to stock immunocastrated pork. Raising entire (uncastrated) males with genetic selection for low-taint animals offers another alternative, and detecting taint at slaughter using sensor technology provides a third option, but immunocastration currently offers the most practical welfare improvement at scale.